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Abstract
Introduction: Early initiation of appropriate antimicrobial treatment is a cornerstone in managing pneumonia.
Because microbiologic processing may not be available around the clock, optimal storage of specimens is essential
for accurate microbiologic identification of pathogenetic bacteria. The aim of our study was to determine the
accuracy of two commonly used storage approaches for delayed processing of bronchoalveolar lavage in critically
ill patients with suspected pneumonia.
Methods: This study included 132 patients with clinically suspected pneumonia at two medical intensive care units
of a tertiary care hospital. Bronchoalveolar lavage samples were obtained and divided into three aliquots: one was
used for immediate culture, and two, for delayed culture (DC) after storage for 24 hours at 4°C (DC4) and -80°C
(DC-80), respectively.
Results: Of 259 bronchoalveolar lavage samples, 84 (32.4%) were positive after immediate culture with 115
relevant culture counts (≥104 colony-forming units/ml). Reduced (<104 colony-forming units/ml) or no growth of
four and 57 of these isolates was observed in DC4 and DC-80, respectively. The difference between mean bias of
immediate culture and DC4 (-0.035; limits of agreement, -0.977 to 0.906) and immediate culture and DC-80 (-1.832;
limits of agreement, -4.914 to 1.267) was -1.788 ± 1.682 (P < 0.0001). Sensitivity and negative predictive value were
96.5% and 97.8% for DC4 and 50.4% and 75.4% for DC-80, respectively; the differences were statistically significant
(P < 0.0001).
Conclusions: Bronchoalveolar lavage samples can be processed for culture when stored up to 24 hours at 4°C
without loss of diagnostic accuracy. Delayed culturing after storage at -80°C may not be reliable, in particular with
regard to Gram-negative bacteria.
Introduction
Hospital-acquired pneumonia is a serious and frequent
infection at the intensive care unit (ICU) [1,2]. Despite
advances in prevention and therapy, pneumonia remains a
major cause of morbidity and mortality in the ICU [3,4].
Considering the serious prognosis, associated with delayed
or inappropriate antimicrobial therapy [5,6] pathogen
identification may help to guide treatment and manage-
ment of pneumonia in the ICU.
Despite the debate of the efficacy of invasive versus non-
invasive approaches [7,8], many teams around the world
perform distal bronchial sampling for managing pneumo-
nia [9]. Because prior antibiotic treatment may significantly
decrease the sensitivity of culture [10], the specimens
should ideally be obtained before initiation of treatment.
However, in most centers, microbiologic processing is not
available around the clock (for example, at night or during
weekends), and the appropriate storage of specimens may
be of crucial importance to prevent loss of diagnostic
accuracy of microbiologic culture.
Freezing and refrigeration of specimens are two labora-
tory approaches widely used if immediate specimen
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processing is not available. In a previous study, overnight
refrigeration at 4°C of protected specimen brush (PSB)
samples did not affect growth of potential pathogens, with
the exception of Haemophilus influenzae [11]. In a further
study, specimens obtained by PSB were stored at -80°C for
24 hours with good reliability of culture, except for Strep-
tococcus pneumoniae and Escherichia coli [12]. Finally,
delayed processing of bronchoalveolar lavage (BAL) and
plugged telescopic catheter (PTC) specimens after storage
at 4°C for 24 hours was also shown to be an acceptable
alternative when immediate microbiologic processing was
not feasible [13,14].
Given the scarce data available regarding the optimal
storage conditions of respiratory specimens, we aimed to
compare refrigeration with freezing, to define the most
appropriate storage condition of BAL specimens in clinical
practice, when immediate culture is not available.
Materials and methods
Patients and inclusion criteria
The study was performed at two medical ICUs (8 beds
each) of a tertiary care facility. All patients admitted to the
ICUs during the observation period were screened pro-
spectively for clinical suspicion of ventilator-associated
pneumonia based on new pulmonary infiltrates on chest
radiographs and at least two of the following: fever (>38.5°
C) or hypothermia (<36.5°C), leukocytosis (>10 × 109/L)
or leukopenia (<3 × 109/L), and purulent tracheal aspirates
[15]; patients fulfilling these criteria were included in the
study.
Severity of acute illness on intensive care unit admis-
sion was assessed by using the Simplified Acute Physiol-
ogy Score II (SAPS II) [16].
The protocol did not interfere with the clinical routine.
BAL via fiberoptic bronchoscopy was requested by the
attending physician to investigate the suspicion of pneu-
monia and to provide guidance for antimicrobial treat-
ment. Thereafter, BAL fluid was divided into three
aliquots. One was immediately processed as usual and was
used for the clinical decision-making process. The two
other aliquots were used to assess the diagnostic accuracy
of two storage methods for delayed culture and were not
involved in the clinical decision-making process.
The current investigation was performed within the
frame of a clinical study, which has been approved by
the ethics committee of the Medical University Vienna
(Number 303/2007). As our subjects were unable to
consent because of sedation and analgesia, the ethics
committee waived the need for patient consent.
Fiberoptic bronchoscopy and bronchoalveolar lavage
A 5.2-mm (outside diameter) fiberoptic bronchoscope
(Olympus, BF P 200; Olympus Optical of America, New
Hyde Park, NY, USA) was introduced through a special
adaptor (catheter mount, Dar-Breathing-System; Tyco
Healthcare, Milano, Italy) and advanced close to the
lobe at the site of the radiographic signs without suc-
tioning to avoid contamination. Sterile isotonic saline
(100 ml) was instilled in 20-ml portions. The first 20 ml
was removed to avoid bacterial contamination, whereas
the remaining BAL fluid was used for culture. As all
ICU patients were already intubated, bronchoscopy was
performed via endotracheal tube.
BAL fluid processing
BAL fluid was immediately brought to the microbiologic
laboratory (within 20 minutes after bronchoscopy),
where it was separated into three aliquots: one was used
for immediate culture (IC), and two, for delayed culture
(DC) after storage for 24 hours at 4°C (DC4) and -80°C
(DC-80), respectively.
Specimens were processed by using standard routine
methods for microscopy, culture, identification, and
antimicrobial susceptibility testing (Health Protection
Agency: Investigation of bronchoalveolar lavage, sputum
and associated specimens. National Standard Method
2008 BSOP 57 Issue 2.2.). Culture was performed semi-
quantitatively by using a calibrated loop to plate out 10
μl of fluid on each of the used agar media.
All identified microorganisms were recorded. Because
microbiologic proof of infection when analyzing BAL is
defined as growth of ≥104 colony-forming units (CFUs)/
ml of potential pathogens [17], only those isolates fulfilling
these criteria were considered for statistical analysis of the
performance characteristics of delayed culture. Thus, no
or reduced growth in the delayed processed aliquots, as
compared with the corresponding IC aliquots, was
recorded and analyzed.
Statistics
Data are presented as median and 25% to 75% inter-
quartile range (IQR) or mean and standard deviation
(SD), as appropriate. Sensitivity, specificity, and predic-
tive values were calculated by using standard formulas
and compared by using the McNemar test.
Because the same microorganisms could be detected in
different samples of the same patient or different samples
of the same bronchoscopy, we calculated robust 95%
confidence intervals of the test-performance characteris-
tics to correct for clustering within patients and within
BAL samples.
Agreement between immediate and delayed cultures was
assessed by the method of Bland and Altman [18], pre-
sented as mean bias and limits of agreement (1.96 × SD of
the difference). Mean bias of DC4 and DC-80 was
compared by using a paired t test. Proportions were com-
pared by using the c2 test. A two-sided P value of less
than 0.05 was considered statistically significant. Statistical
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calculations were performed by using Stata 8.0 for Mac
(Stata Corp, College Station, TX, USA).
Results
Patient characteristics
During a 3-year period 132 patients (46 female and 86
men) with a median age of 62.0 (48.0 to 70.5) years and
a median SAPS II on admission of 54.0 (39.3 to 66.0)
were included in the study. In 105 patients, one
bronchoscopy was performed, from which 166 samples
were obtained. In 23 patients, two bronchoscopies, in
two patients, three bronchoscopies, and in two further
patients, four bronchoscopies were performed, from
which 72 samples, eight samples, and 13 samples were
obtained, respectively. On average, 1.3 (± 0.6) bronchos-
copies were performed, and 2.0 (± 1.1) samples were
obtained per patient. In 70 patients, the bronchoscopies
were performed bilaterally. All patients were mechani-
cally ventilated. Median overall length of mechanical
ventilation (MV) and median length of MV before
bronchoscopy were 11 (7 to 20) and 5 (1 to 11) days,
respectively. Median ICU length of stay was 17 (9 to 31)
days, and ICU mortality was 28.2%.
Immediate culture
Of a total of 259 BAL samples, growth was observed in
216 (83.4%), and significant growth (≥104 CFU/ml) of at
least one potential pathogen in 84 (32.4%); the latter ori-
ginated from 55 patients. Overall, 115 potential patho-
gens yielded relevant counts (≥104 CFU/ml); numbers of
potential pathogens recovered per specimen type are
shown in Table 1. Of these 115 microorganisms, 18 dif-
ferent bacterial species were identified; 15 species of
Gram-negative bacteria, accounting for 74 isolates, and
three species of Gram-positive bacteria, accounting for
41 isolates. All microorganisms cultured from immedi-
ately processed specimens are shown in Table 2. Of the
115 potential pathogens, 56 were isolated from 32 speci-
mens originating from 17 patients, of a total of 39
patients having not received any antimicrobial treatment
for at least 72 hours before bronchoscopy; 59 were iso-
lated from 52 specimens originating from 38 patients of
a total of 106 patients having received antimicrobial
treatment for at least 24 hours (median 96, 48 to 192
hours) before bronchoscopy. BAL specimens before and
after antimicrobial therapy were obtained from 13
patients, who were therefore counted on both the
untreated and the treated groups of patients. The ratio of
the number of potential pathogens to the total number of
patients was statistically significantly higher in the
untreated than in the treated group (56 of 39 versus 59of
106; OR, 2.6; 95% CI, 1.5 to 4.5; P = 0.0004); however, this
did not apply for the ratio of the number of corresponding
patients to the total number of patients in each group
(17of 39 versus 38 of 106; OR, 1.2; 95% CI, 0.6 to 2.5; P =
0.599). Furthermore, the ratio of samples with significant
growth to the number of specimens examined was 32
(42.1%) of 76 in untreated and 52 (28.4%) of 183 in treated
patients (OR, 1.5; 95% CI, 0.9 to 2.6; P = 0.139).
Delayed culture
Considering 104 CFU/ml as the threshold for significant
pathogen growth, IC and DC4 paired samples were con-
cordant in 257 (99.2%) of 259 cases; thus, the counts of
four potential pathogens (cultured from two samples, two
pathogens each; Table 1) decreased below 104 CFU/ml on
storage at 4°C. The decrease of cfu counts in DC4 as com-
pared with IC is shown in Table 2 for each of the identi-
fied species. The mean decrease of Gram-positive and
Gram-negative bacteria was 0.098 ± 0.374 log10 and 0.000
± 0.523 log10, respectively. The performance characteris-
tics of DC4 as compared to IC are shown in Table 3. The
agreement between cfu counts of IC and DC4 is shown in
Figure 1. Mean bias was -0.035, and limits of agreement
were -0.977 to 0.906.
IC and DC-80 paired samples were concordant in 213
(82.2%) of 259 cases with respect to the threshold of 104
CFU/ml for significant pathogen growth; the counts of 57
potential pathogens (cultured from a total of 46 samples;
Table 1) decreased below 104 CFU/ml on storage at -80°C.
In fact, 16 Gram-negative bacteria, of which eight were P.
aeruginosa, did not grow at all. The decrease of cfu counts
in DC-80 as compared with IC is shown in Table 2 for
each of the identified species. The mean decrease of
Gram-positive and Gram-negative bacteria was 0.342 ±
0.728 log10 and 2.595 ± 1.334 log10, respectively. The per-
formance characteristics of DC-80 in comparison to IC
are shown in Table 3. The agreement between cfu counts
of IC and DC-80 is shown in Figure 2. Mean bias was
-1.832, and limits of agreement were -4.917 to 1.267.
The difference between mean bias of IC versus DC4
and IC versus DC-80 was -1.788 ± 1.682 (P < 0.0001).
In six BAL samples, cfu counts in DC4 exceeded by one
log10 those found in IC. However, in none of the 175
samples, which did not show any significant growth of
potential pathogens, the count of any of the pathogens
detected was ≥104 CFU/ml on storage at 4°C or -80°C.
Table 1 Specimen type and number of potential
pathogens (≥104 CFU/ml)
No. potential pathogens IC DC4 DC-80
0 175 177 221
1 61 61 23
2 15 13 10
3 8 8 5
Total 259 259 259
IC, immediate culture; DC4, delayed culture after storage at 4°C; DC-80,
delayed culture after storage at -80°C.
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Samples showing no growth in IC were sterile also in
both DC4 and DC-80.
Prior antimicrobial treatment did not affect growth of
potential pathogens in relevant counts in DC4; thus, two
of 56 and two of 59 potential pathogens isolated from
untreated and treated patients, respectively, showed
reduction in growth below 104 CFU/ml. In DC-80, how-
ever, antimicrobial treatment was significantly associated
with failure to detect relevant counts of potential patho-
gens; the respective numbers were 20 of 56 and 37 of
59 (P = 0.004).
Because the same microorganisms could be detected
in different samples of the same patient or different
samples from the same bronchoscopy, we calculated
robust 95% confidence intervals of the test-performance
characteristics to correct for clustering within patients
and within BAL samples. Correction for clustering
within patients and BAL samples did not affect the
performance characteristics of DC4 and DC-80 (data
not shown), which were shown to differ statistically
significantly (P < 0.0001) with regard to sensitivity and
negative predictive value (Table 3).
Discussion
In the present study, the influence of storage conditions
on growth of pathogens potentially causing pneumonia in
ICU patients was investigated in a large number of BAL
specimens. Microbiologic culture was highly sensitive on
storage of BAL at 4°C for up to 24 hours; however, a
considerable loss of sensitivity was observed after storage
at -80°C.
Although the benefit of detecting the causative organism
in ventilator-associated pneumonia (VAP) is undisputed,
the approach by which this can be achieved is under
debate. The impact of microbiologic findings of distal
bronchial sampling by BAL on mortality of ICU patients
has been discussed controversially [7,8,19]. Recent trials
failed to prove the advantage of BAL on outcome and
antibiotic use in comparison with other less invasive or
noninvasive diagnostic approaches [8,20-22]. Conversely,
it has been shown that, compared with a noninvasive man-
agement strategy, an invasive management strategy is sig-
nificantly associated with fewer deaths at 14 days, earlier
attenuation of organ dysfunction, and less antibiotic use in
patients suspected of having VAP [19]. Furthermore,
Table 2 Significant growth (≥104 CFU/ml) of potential pathogens recovered from IC, DC4, and DC-80
Species of potential pathogens IC DC4 Mean decrease ± SD DC-80 Mean Decrease ± SD
Gram-positive bacteria
Staphylococcus aureus 21 20 0.190 ± 0.510 19 0.238 ± 0.590
Enterococcus faecalis 15 15 0 13 0.400 ± 0.910
Streptococcus pneumoniae 5 5 0 4 0.600 ± 0.890
Gram-negative bacteria
Pseudomonas aeruginosa 28 28 -0.071 ± 0.460 3 3.250 ± 1.290
Escherichia coli 11 9 0.182 ± 0.400 6 2.180 ± 1.080
Haemophilus influenzae 8 8 0 8 1.750 ± 0.710
Enterobacter cloacae 7 7 0.143 ± 0.690 3 2.000 ± 1.000
Klebsiella oxytoca 3 3 0 0 -
Klebsiella pneumoniae 3 3 0 0 3.000 ± 1.000
Stenotrophomonas maltophilia 3 3 0.333 ± 0.580 1 2.000 ± 1.000
Hafnia alvei 2 2 -0.500 ± 0.710 0 1.000 ± 0.000
Morganella morganii 2 2 0 0 2.000 ± 1.000
Acinetobacter baumannii 2 2 0 1 0.500 ± 0.710
Citrobacter koseri 1 1 - 0 -
Enterobacter aerogenes 1 1 - 0 -
Pantoea spp. 1 0 - 0 -
Providencia alcalifaciens 1 1 - 0 -
Serratia marcescens 1 1 - 0 -
Total 115 111 58
IC, immediate culture; DC4, delayed culture after storage at 4°C; DC-80, delayed culture after storage at -80°C. Mean decrease expressed as log10 of CFU/ml ± SD
Table 3 Performance characteristics of DC4 and DC-80 in
comparison to IC






Specificity 100% (97.3-100) 100% (97.3-100) 0.99








DC4, delayed culture after storage at 4°C; DC-80, delayed culture after storage
at -80°C; IC, immediate culture; CI, confidence interval.
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invasive diagnostic testing may increase the physician’s
confidence in diagnosis and management of VAP and may
allow greater ability to limit or discontinue antibiotic treat-
ment [23]. However, BAL is considered a reliable method
for establishing a definite etiologic diagnosis of pneumo-
nia, and ICU teams will continue to use BAL for managing
VAP and deriving clinical decisions. However, the clinical
decision-making process, and consequently the outcome
for patients with VAP, will depend on the quality of the
clinical specimen, which may be affected to a considerable
extent by inappropriate storage conditions.
In comparison with immediate microbiologic culture,
our results demonstrate an excellent test performance
after storage of BAL specimens at 4°C for up to 24
hours, but a considerable decrease of bacterial growth
on storage at -80°C. This effect was more pronounced
in the Gram-negative bacterial spectrum and resulted in
a highly significant reduction of culture sensitivity and
negative predictive value. This is of importance because
the prognosis for aerobic, Gram-negative bacilli in VAP
is considerably worse than that for infection with Gram-
positive pathogens, even when microorganisms are fully
susceptible to antibiotics [24]. Thus, the loss of diagnos-
tic performance for Gram-negative pathogens after sto-
rage of BAL at -80°C may lead to an underestimation of
a particularly serious clinical condition. The highest
reduction was observed in the bacterial counts of Pseu-
domonas aeruginosa isolates (3.25 ± 1.29 log10). Further-
more, of the 28 isolates of this pathogen grown in
relevant counts during routine immediate culture, only
three exceeded 104 CFU/ml in samples stored at -80°C
before culture. This is of particular importance, because in
nearly all studies, P. aeruginosa is the most frequently iso-
lated bacterium in VAP, and episodes caused by the
pathogen are associated with a significantly higher mortal-
ity than are those caused by other microorganisms
[25-29]. In a study by Fagon et al. [27], after matching for
the severity of underlying disease and various other impor-
tant variables, the attributable mortality was 42.8%, and
the risk ratio for death was 2.5 for pneumonia due to P.
aeruginosa or Acinetobacter species. Thus, early pathogen
identification and initiation of appropriate therapy is cru-
cial in Pseudomonas pneumonia. Therefore, storage of
BAL at -80°C resulting in impaired growth of P. aerugi-
nosa and other pathogens of VAP should be considered
inappropriate in clinical practice.
In the present study, prior antimicrobial treatment
was associated in a statistically significant manner with
failure to detect sufficient counts of potential pathogens
after storage at -80°C. Thus, microorganisms may be
more susceptible to freezing/thawing on exposure to
antimicrobials, and treatment may be one of the reasons
for the considerably lower sensitivity of culture subse-
quent to this procedure.
In the study by Georges et al. [12], growth of P. aeru-
ginosa was only moderately affected by storage of PSB
specimens at -80°C, and none of the isolates failed to
grow in clinically relevant counts (≥103 CFU/ml) after
sample freezing. In this previous study, a mean overall
decrease of bacterial counts of 1.00 ± 1.44 log10 was
found, and the authors concluded that PSB specimens
can be frozen at -80°C with good diagnostic reliability of
culture, except for Streptococcus pneumoniae and
Escherichia coli. The impact of sample freezing on
growth of E. coli but not of S. pneumoniae is in accor-
dance with the data of the present study. Apparent dis-
crepancies between the previous and the current study
may be due mainly to the different consistency and nat-
ure of PSB as compared with BAL and the rather small
number of samples analyzed by Georges et al. [12].
In contrast to the significant impact of BAL specimen
freezing on growth of Gram-negative bacteria, refrigera-
tion at 4°C for 24 hours was shown to affect the culture
of these microorganisms to only a minor extent. This
finding is in accordance with data presented in previous
smaller studies, suggesting that 24 hours of refrigeration
Figure 1 Agreement of bacterial counts from paired IC and
DC4 of all identified species (n = 115). Mean bias (dotted line),
limits of agreement (1.96*SD of the difference, dashed line). IC,
immediate culture; DC4, delayed culture after storage at 4°C.
Figure 2 Agreement of bacterial counts from paired IC and
DC-80 of all identified species (n = 115). Mean bias (dotted
line), limits of agreement (1.96*SD of the difference, dashed line).
IC, immediate culture; DC-80, delayed culture after storage at
-80°C.
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of PTC and BAL specimens does not result in loss of
the diagnostic accuracy of culture [13,14,30]. Immediate
storage and rapid processing may have had an impact
on the good performance of culture in specimens stored
at 4°C in this and previous studies. However, because
refrigeration is available and easily practicable in most
intensive care units, BAL sampling could be performed
around the clock with the certainty that this will not
affect the diagnostic accuracy of subsequent culture.
In a study by Forceville et al. [30], storage of PSB and
BAL specimens for 48 hours at 4°C revealed an accepta-
ble reproducibility of culture, except for Haemophilus
influenzae. The authors state that a 1-log reduction of
the cut-off for significant growth has been associated
with a better performance of culture subsequent to sto-
rage of specimens. In the present study, the use of ≥103
CFU/ml as threshold did not affect the performance of
DC4. In contrast, the sensitivity and negative predictive
value of DC-80 increased to 73.9% and 85.4%, respec-
tively, but overall values remained considerably lower in
comparison to DC4.
However, the fact that the effect of longer periods of
refrigeration has not been investigated may be a limita-
tion of the present study, because this may be of parti-
cular importance in facilities where specimen processing
(for example, during the weekend) is not feasible.
Furthermore, although storage conditions evaluated here
and especially refrigeration are most commonly used, it
may be of importance to elucidate whether, for example,
more-gentle freezing/thawing conditions may be also
appropriate for the storage of BAL specimens. Finally,
sample quality in different storage conditions and its
influence on culture results was not evaluated and may
represent a further limitation of the present study.
Conclusions
Our study clearly demonstrates that storage of BAL spe-
cimens at 4°C for up to 24 hours allows the accurate
detection of VAP pathogens by culture. Therefore, even
if microbiologic processing may not be available 24 hours
per day, BAL sampling can be performed around the
clock without loss of diagnostic accuracy. Storage at -80°
C inhibits growth of Gram-negative bacteria to a consid-
erable extent and therefore cannot be recommended for
clinical use.
Key messages
• Bronchoalveolar lavage samples can be processed
for culture when stored up to 24 hours at 4°C with-
out loss of diagnostic accuracy.
• Storage at -80°C inhibits growth of Gram-negative
bacteria to a considerable extent and therefore can-
not be recommended for clinical use.
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